Sign in to follow
Search Results

0 results for 'Sanofi SA'

You can use to get even better search results
April 05, 2005 |

David Katz: Frequent Flyer

2 minute read
October 09, 2009 |

In re Sanofi-Aventis Securities Litigation

Material Omission, Scienter Not Shown in Fraud Suit Stemming From FDA Denial of Anti-Obesity Drug
1 minute read
October 02, 2009 |

Mergers & Acquisitions

New Jersey mergers and acquisitions.
1 minute read
February 01, 2005 |

A French Affair

Hen we last visited Laurent Cohen-Tanugi, the 47-year-old lawyer was excited to be the new senior vice president for legal affairs and general counsel at the Paris-based pharmaceutical giant Sanofi-Synth�labo [A Renaissance Man, January 2004]. Cohen-Tanugi is now rethinking this attitude-from the vantage point of his new job as a Paris-based partner at Skadden, Arps, Slate, Meagher & Flom. In France, Cohen-Tanugi is considered a rare breed: a lawyer and a public intellectual-the author of six books
3 minute read
June 01, 2007 |

Focus Europe: The Arbitration Scorecard

74 minute read
May 30, 2006 |

Drug Makers Delay Generics Hitting Market

The marketers of the world's second-largest-selling drug dodged a major threat to their revenues by reaching a deal to keep a generic competitor at bay until at least 2011. Now, 10 lawsuits have been filed over the settlement Sanofi-Aventis SA and Bristol-Myers Squibb reached with Apotex, a generic manufacturer challenging blood thinner Plavix's patent. The suits, filed by businesses, unions and health plans, allege the deal violates antitrust laws by denying access to cheap, generic versions of Plavix.
6 minute read
May 30, 2006 |

Drug Makers Delay Generics Hitting Market

The marketers of the world's second-largest-selling drug dodged a major threat to their revenues by reaching a deal to keep a generic competitor at bay until at least 2011. Now, 10 lawsuits have been filed over the settlement Sanofi-Aventis SA and Bristol-Myers Squibb reached with Apotex, a generic manufacturer challenging blood thinner Plavix's patent. The suits, filed by businesses, unions and health plans, allege the deal violates antitrust laws by denying access to cheap, generic versions of Plavix.
6 minute read
August 30, 2010 |

Stocks dip as investors enter week cautiously

Stocks edged lower today as investors took a cautious approach to trading before the government's latest report on the jobs market.
4 minute read
March 21, 2011 |

Big Deals

8 minute read
July 01, 2011 |

Big Deals

The law firms that handled the biggest recent deals in Germany, France, United Kingdom, Spain, Italy, and the Nordic countries.
6 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources